ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
Project Title | Institution / Principal Investigator(s) | Grant Type | Year | State |
---|---|---|---|---|
Selective inhibition of nuclear export as a novel therapeutic strategy in AML | Dana-Farber Cancer Institute / Julia Etchin | Young Investigator Grants | 2012 | Massachusetts |
Therapeutic Targets and Molecular Mechanisms in Childhood Brainstem Tumors | University Health Network - Toronto Western Research Institute / Jerome Fortin, PhD | Young Investigator Grants | 2019 | Ontario |
Critical Contributions of CRM1 to Leukemogenesis | University of Vermont / Jessica Linda Heath, MD | Young Investigator Grants | 2015 | Vermont |
Developing an accurate genetic model for rhabdomyosarcoma therapy | Children’s Research Institute / Dawn Chandler, PhD | Young Investigator Grants | 2007 | District of Columbia |
Targeted Polymeric Parthenolide Carriers to Treat Childhood AML | University of Rochester / Danielle Benoit | Young Investigator Grants | 2010 | New York |
The Role of Mxi1 in the Modulation N-Myc Function in Neuroblastoma | Duke University / Michael Armstrong | Young Investigator Grants | 2011 | North Carolina |
Novel Role of Hematopoietic Stem Cells in Immunologic Rejection of Malignant Pediatric Brain Tumors | University of Florida / Catherine Flores, PhD | Young Investigator Grants | 2015 | Florida |
Immunotherapy for Osteosarcoma and Ewing sarcoma | Baylor College of Medicine / Nabil Ahmed, MD, MSc | Young Investigator Grants | 2007 | Texas |
Exploring a novel immunotherapy: cooperation of endogenous CD8+ t-cells and exogenous, allogeneic CD4+ t-cells. | The Johns Hopkins University School of Medicine / Heather Symons | Young Investigator Grants | 2009 | Maryland |
Engager T Cells: A Novel Immunotherapeutic for AML | University of Michigan / Challice Bonifant, MD, PhD | Young Investigator Grants | 2015 | Michigan |